pharmaceutical competition
Media
Moderna Stock Plunges as Company Slashes 2025 Revenue Forecast and Announces Major Cost Cuts
Moderna (NASDAQ: MRNA) shares tumbled 18% in premarket trading on Monday after the biotechnology company significantly lowered its 2025 revenue forecast and announced...
Billionairesworld's billionaires
Cai Hongbin: A Pillar of Innovation in China’s Pharmaceutical Industry
Cai Hongbin has emerged as a formidable figure in China’s pharmaceutical sector, thanks to his significant contributions to Jiangsu Hengrui Medicine, one of...
